Applied Biosystems to Hold New Product Webcast and Conference Call.

Business Editors/Health & Medical Writers

FOSTER CITY, Calif.--(BW HealthWire)--Jan. 7, 2002

Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced it will hold a webcast and conference call on Tuesday, January 8, 2002 at 11:00 a.m. ET to discuss new proteomics products. Interested parties may access the webcast by visiting the Applied Biosystems homepage at www.appliedbiosystems.com. Those who would like to participate in the conference call should dial 1-888-632-5950 and ask for the "Applied Biosystems conference call" between 10:45 and 11:00 a.m. ET. International participants should call ([phone]. A conference call replay is expected to be available approximately two hours after the call's completion by calling 1-800-642-1687 (U.S. and Canada) and 1-706-645-9291 (international). Replay code is 2836255.

About Applera Corporation and Applied Biosystems

Applera Corporation comprises two operating groups. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries, leading to the development of new pharmaceuticals, and to conduct standardized testing. Applied Biosystems is headquartered in Foster City, Calif., and reported sales of $1.6 billion during fiscal 2001. The Celera Genomics Group, headquartered in Rockville, Md., is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera's businesses are its online information business and its therapeutics discovery business. The online information business is a leading provider of information based on the human genome and other biological and medical information. Through the therapeutic discovery business, Celera intends to leverage its genomic and proteomic capabilities to identify drug targets and diagnostic marker candidates, and to discover novel therapeutic candidates. Celera Diagnostics has been established as a joint venture between Applied Biosystems and Celera Genomics. This new venture is focused on discovery, development and commercialization of novel diagnostic tests. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at www.applera.com, or by telephoning 1-800-762-6923. Information about Applied Biosystems is available at www.appliedbiosystems.com.